The transfer is a patent for using #TCellReceptors (TCRs) to treat solid tumors from #HPV, one of the only patents for treating solid tumors with TCRs. The transfer's beneficiary is #ScarletTCR, a Delaware company with no website or SEC filings and ownership shrouded in mystery:

https://www.bizapedia.com/de/scarlet-tcr-inc.html

One person who pays attention to this sort of thing is @jameslove, founder of #KnowledgeEcologyInternational, a nonprofit that has worked for decades for access to medicines.

11/